A Randomized, Double-Blind, Parallel, Placebo or Amlodipine-Controlled Study of the Effects of Losartan on Proteinuria in Pediatric Patients With or Without Hypertension

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-006415-74

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To study the effects of losartan compared to placebo (nonhypertensives) or amlodipine (hypertensives) on reduction of proteinuria in children and adolescents up to 17 years of age with hypertension (if >6 years old) and without hypertension (if >1 year old). To determine whether losartan is well tolerated at a dose of up to 1.4 mg/kg/day in pediatric patients with proteinuria.


Critère d'inclusion

  • Proteinuria